Статья

Antibodies in serum of convalescent patients following mild COVID-19 do not always prevent virus-receptor binding

P. Gattinger, K. Borochova, Y. Dorofeeva, R. Henning, R. Kiss, B. Kratzer, B. Mühl, T. Perkmann, D. Trapin, M. Trella, P. Ettel, I. Tulaeva, W. Pickl, R. Valenta,
2021

Цитирование

Похожие публикации

Источник

Версии

  • 1. Version of Record от 2021-04-27

Метаданные

Об авторах
  • P. Gattinger
    Department of Pathophysiology and Allergy Research, Division of Immunopathology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria
  • K. Borochova
    Viravaxx, Vienna, Austria
  • Y. Dorofeeva
    Institute of Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria
  • R. Henning
    Labors.at, Vienna, Austria
  • R. Kiss
    Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria
  • B. Kratzer
    Laboratory for Immunopathology, Department of Clinical Immunology and Allergy, Sechenov First Moscow State Medical University, Moscow, Russian Federation
  • B. Mühl
    NRC Institute of Immunology FMBA of Russia, Moscow, Russian Federation
  • T. Perkmann
    Karl Landsteiner University of Health Sciences, Krems, Austria
  • D. Trapin
  • M. Trella
  • P. Ettel
  • I. Tulaeva
  • W. Pickl
  • R. Valenta
Название журнала
  • Allergy: European Journal of Allergy and Clinical Immunology
Том
  • 76
Выпуск
  • 3
Страницы
  • 878-883
Издатель
  • Blackwell Publishing Ltd
Тип документа
  • Letter
Тип лицензии Creative Commons
  • CC
Правовой статус документа
  • Свободная лицензия
Источник
  • scopus